Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assay

This publication has 14 references indexed in Scilit:

• HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial
  The Lancet, 2019
• Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners
  The Journal of Infectious Diseases, 2018
• Identification of preferential CD4+ T-cell targets for HIV infection in the cervix
  Mucosal Immunology, 2016
• Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies
  The Lancet Infectious Diseases, 2015
• Hormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis
  PLOS Medicine, 2015
• Distinct Characteristics of Endometrial and Decidual Macrophages and Regulation of Their Permissivity to HIV-1 Infection by SAMHD1
  Journal of Virology, 2015
• Incident HIV during Pregnancy and Postpartum and Risk of Mother-to-Child HIV Transmission: A Systematic Review and Meta-Analysis
  PLOS Medicine, 2014
• Contribution of sexually transmitted infections to the sexual transmission of HIV
  Current Opinion in HIV and AIDS, 2010
• Semen-Derived Amyloid Fibrils Drastically Enhance HIV Infection
  Cell, 2007
• A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
  Nature Biotechnology, 2002